Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07ALM
|
||||
| Former ID |
DNC006854
|
||||
| Drug Name |
N4-(4-chlorobenzyl)-2,4-diaminobutanoylpiperidine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528314] | ||
| Formula |
C16H24ClN3O
|
||||
| Canonical SMILES |
C1CCN(CC1)C(=O)C(CCNCC2=CC=C(C=C2)Cl)N
|
||||
| InChI |
1S/C16H24ClN3O/c17-14-6-4-13(5-7-14)12-19-9-8-15(18)16(21)20-10-2-1-3-11-20/h4-7,15,19H,1-3,8-12,18H2/t15-/m0/s1
|
||||
| InChIKey |
DNVZYSMOLXCOLY-HNNXBMFYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [528314] | |
| KEGG Pathway | Protein digestion and absorption | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.